Extract from the Register of European Patents

EP About this file: EP2774925

EP2774925 - Heterocyclic modulators of ATP-binding cassette transporters [Right-click to bookmark this link]
Former [2014/37]Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters
[2016/03]
StatusNo opposition filed within time limit
Status updated on  03.11.2017
Database last updated on 01.04.2026
FormerThe patent has been granted
Status updated on  25.11.2016
FormerGrant of patent is intended
Status updated on  16.11.2016
Most recent event   Tooltip03.11.2017No opposition filed within time limitpublished on 06.12.2017  [2017/49]
Applicant(s)For all designated states
Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston, MA 02210 / US
[2016/52]
Former [2014/37]For all designated states
Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston, MA 02210 / US
Inventor(s)01 / Hadida Ruah, Sarah
2356 Torrey Pines 16
La Jolla, CA 92037 / US
02 / Hamilton, Matthew
24 Mockingbird Road
Hackettstown, NJ 07840 / US
03 / Miller, Mark
5075 La Jolla Blvd., 9
San Diego, CA 92109 / US
04 / Grootenhuis, Peter D. J.
4801 Riding Ridge Road
San Diego, CA 92130 / US
05 / Bear, Brian
5108 Spencer Ct.
Oceanside, CA 92057 / US
06 / McCarthy, Jason
2274 Carol View Drive Apt. 112
Cardiff By The Sea, CA 92007 / US
07 / Zhou, Jinglan
4466 Shorepointe Way
San Diego, CA 92130 / US
 [2014/37]
Representative(s)Oates, Edward Christopher, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2014/45]
Former [2014/44]Goodfellow, Hugh Robin, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
Former [2014/37]Cohausz & Florack
Patent- und Rechtsanwälte
Partnerschaftsgesellschaft
Bleichstraße 14
40211 Düsseldorf / DE
Application number, filing date14163968.208.11.2006
[2014/37]
Priority number, dateUS20050734506P08.11.2005         Original published format: US 734506 P
US20050754086P27.12.2005         Original published format: US 754086 P
US20060802458P22.05.2006         Original published format: US 802458 P
[2014/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2774925
Date:10.09.2014
Language:EN
[2014/37]
Type: B1 Patent specification 
No.:EP2774925
Date:28.12.2016
Language:EN
[2016/52]
Search report(s)(Supplementary) European search report - dispatched on:EP13.08.2014
ClassificationIPC:C07D405/12, A61K31/443, A61P11/00
[2014/37]
CPC:
C07D405/12 (EP,KR,RU,US); G01N33/6872 (KR); A61K31/443 (RU,US);
A61K31/444 (US); A61K31/4525 (KR); A61K31/4545 (US);
A61K31/47 (US); A61K31/4709 (US); A61K31/496 (US);
A61K31/497 (US); A61K31/501 (US); A61K31/506 (US);
A61K31/5377 (US); A61K45/06 (US); A61P1/00 (EP);
A61P11/00 (EP,RU); A61P13/00 (EP); A61P13/02 (EP);
A61P13/12 (EP); A61P17/00 (EP); A61P19/00 (EP);
A61P19/04 (EP); A61P19/08 (EP); A61P21/00 (EP);
A61P21/02 (EP); A61P21/04 (EP); A61P25/00 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P27/04 (EP); A61P3/00 (EP);
A61P3/06 (EP); A61P3/08 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P43/00 (EP); A61P5/00 (EP);
A61P5/14 (EP); A61P5/16 (EP); A61P5/18 (EP);
A61P5/50 (EP); A61P7/00 (EP); A61P7/02 (EP);
A61P7/12 (EP); A61P9/00 (EP); C07D317/12 (EP,US);
C07D405/14 (EP,US); C07K14/4712 (KR) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/52]
Former [2014/37]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Heterocyclische Modulatoren von ATP-bindenden Kassettentransportern[2016/03]
English:Heterocyclic modulators of ATP-binding cassette transporters[2016/03]
French:Modulateurs hétérocycliques de transporteurs à cassette liant l'ATP[2016/03]
Former [2014/37]Pharmazeutische Zusammensetzung mit einem heterocyclischen Modulator ATP-bindender Kassettentransporter
Former [2014/37]Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters
Former [2014/37]Composition pharmaceutique contenant un modulateur hétérocyclique de transporteurs à cassette liant l'ATP
Examination procedure04.03.2015Amendment by applicant (claims and/or description)
04.03.2015Examination requested  [2015/16]
27.07.2015Despatch of a communication from the examining division (Time limit: M04)
07.12.2015Reply to a communication from the examining division
21.01.2016Communication of intention to grant the patent
25.05.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
07.07.2016Communication of intention to grant the patent
16.11.2016Fee for grant paid
16.11.2016Fee for publishing/printing paid
16.11.2016Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP06837028.7  / EP1945632
EP10192912.3  / EP2395002
Divisional application(s)EP16205718.6  / EP3208272
EP20150602.9
Opposition(s)29.09.2017No opposition filed within time limit [2017/49]
Fees paidRenewal fee
09.04.2014Renewal fee patent year 03
09.04.2014Renewal fee patent year 04
09.04.2014Renewal fee patent year 05
09.04.2014Renewal fee patent year 06
09.04.2014Renewal fee patent year 07
09.04.2014Renewal fee patent year 08
10.11.2014Renewal fee patent year 09
10.11.2015Renewal fee patent year 10
10.11.2016Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  Tooltipdeleted
[2017/22]
Former [2017/12]LV28.12.2016
Documents cited:Search[A] WO2005075435  (VERTEX PHARMA et al.)
by applicantUS6099562
 US5886026
 US5304121
   GREGORY, R. J. ET AL., NATURE, vol. 347, 1990, pages 382 - 386
   RICH, D. P. ET AL., NATURE, vol. 347, 1990, pages 358 - 362
   RIORDAN, J. R. ET AL., SCIENCE, vol. 245, 1989, pages 1 066 - 1 073
   CUTTING, G. R. ET AL., NATURE, vol. 346, 1990, pages 366 - 369
   DEAN, M. ET AL., CELL, vol. 61, 1990, pages 863 - 870
   KEREM, B-S. ET AL., SCIENCE, vol. 245, 1989, pages 1073 - 1080
   KEREM, B-S ET AL., PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 8447 - 8451
   QUINTON, P. M., FASEB J., vol. 4, 1990, pages 2709 - 2727
   DALEMANS ET AL., NATURE LOND., vol. 354, 1991, pages 526 - 528
   PASYK; FOSKETT, J. CELL. BIOCHEM., vol. 270, 1995, pages 12347 - 50
   ARIDOR M ET AL., NATURE MED., vol. 5, no. 7, 1999, pages 745 - 751
   SHASTRY, B.S. ET AL., NEUROCHEM. INTERNATIONAL, vol. 43, 2003, pages 1 - 7
   RUTISHAUSER, J. ET AL., SWISS MED WKLY, vol. 132, 2002, pages 211 - 222
   MORELLO, JP ET AL., TIPS, vol. 21, 2000, pages 466 - 469
   BROSS P. ET AL., HUMAN MUT., vol. 14, 1999, pages 186 - 198
   HWANG, T. C. ET AL., J. GEN. PHYSIOL., vol. 111, no. 3, 1998, pages 477 - 90
   "Handbook of Chemistry and Physics"
   THOMAS SORRELL: "Organic Chemistry", 1999, UNIVERSITY SCIENCE BOOKS
   "March's Advanced Organic Chemistry", 2001, JOHN WILEY & SONS
   FREIREICH ET AL., CANCER CHEMOTHER. REP, vol. 50, 1966, pages 219
   "Scientific Tables, Geigy Pharmaceuticals", 1970, ARDSLEY, pages: 537
   S. M. BERGE ET AL.: "pharmaceutically acceptable salts in detail", J. PHARMACEUTICAL SCIENCES, vol. 66, 1977, pages 1 - 19
   REMINGTON: "The Science and Practice of Pharmacy", 2005, LIPPINCOTT WILLIAMS & WILKINS
   "Encyclopedia of Pharmaceutical Technology", 1988, MARCEL DEKKER
   GONZALEZ, J. E.; R. Y. TSIEN: "Voltage sensing by fluorescence resonance energy transfer in single cells", BIOPHYS J, vol. 69, no. 4, 1995, pages 1272 - 80, XP000961694
   GONZALEZ, J. E.; R. Y. TSIEN: "Improved indicators of cell membrane potential that use fluorescence resonance energy transfer", CHEM BIOL, vol. 4, no. 4, 1997, pages 269 - 77, XP000961796, DOI: doi:10.1016/S1074-5521(97)90070-3

DOI:   http://dx.doi.org/10.1016/S1074-5521(97)90070-3
   GONZALEZ, J. E., K. OADES ET AL.: "Cell-based assays and instrumentation for screening ion-channel targets", DRUG DISCOV TODAY, vol. 4, no. 9, 1999, pages 431 - 439, XP001026838, DOI: doi:10.1016/S1359-6446(99)01383-5

DOI:   http://dx.doi.org/10.1016/S1359-6446(99)01383-5
   GONZALEZ, J. E.; K. OADES ET AL.: "Cell-based assays and instrumentation for screening ion-channel targets", DRUG DISCOV TODAY, vol. 4, no. 9, 1999, pages 431 - 439, XP001026838, DOI: doi:10.1016/S1359-6446(99)01383-5

DOI:   http://dx.doi.org/10.1016/S1359-6446(99)01383-5
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.